Multiple Low Dose (MLD) therapy: an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
João M. Fernandes Neto(The Netherlands Cancer Institute), René Bernards(The Netherlands Cancer Institute)
Cited by 4
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence
|Nature Cell Biology|2006|610
Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition
|International Journal of Cancer|2013|350
The Cancer SENESCopedia: A delineation of cancer cell senescence
|Cell Reports|2021|200